Infectious Disease Alert – July 1, 2022
July 1, 2022
View Issues
-
Monkeypox in Europe and North America: What to Expect, What to Do
Data on outcomes of monkeypox cases managed in Europe and North America are limited but provide some clues on epidemiology, clinical manifestations, treatment, and outcome.
-
Monkeypox in the United States
The first 17 patients in the United States affected by the current monkeypox outbreak are described. Of note is the absence of reported fever in 10, and the frequent presence of lymphadenopathy, as well as of genital and perianal lesions.
-
Travelers Need Pre-Trip Hepatitis A Vaccination
Hepatitis A continues to be a problem for international travelers in much of the world. More widespread use of hepatitis A vaccine could be warranted.
-
Influenza Vaccination Reduces the Risk of Major Cardiovascular Events
A meta-analysis of six randomized, controlled trials revealed receipt of influenza vaccination reduced the risk of major cardiovascular events compared to the unvaccinated, with 56 patients needing vaccination to prevent one event. Higher-risk patients had 45% reduced risk.
-
Cirrhosis and Infections
Infections in patients with cirrhosis are frequent and potentially lethal, with pneumonia associated with the highest risk for mortality.
-
Getting to the NBA Finals by COVID-19 Vaccine Boosting
Vaccine booster doses were highly effective in preventing infection, whether symptomatic or asymptomatic, with the omicron variant of SARS-CoV-2 in National Basketball Association players and staff.
-
Is There Value in Repeating Blood Cultures While the First Set Is Still Incubating?
The yield from repeat blood cultures is low, suggesting their general use in most patients should be discouraged.
-
Infectious Disease Alert Updates
How Much Should Injectable Cabotegravir for PrEP Cost? Asymptomatic COVID Infection in Healthcare Workers